Search

Agnieszka Boesen

Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1671, 1672, 1648
Total Applications
1050
Issued Applications
614
Pending Applications
117
Abandoned Applications
353

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5112474 [patent_doc_number] => 20070196389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'VIRAL GENE PRODUCTS AND METHODS FOR VACCINATION TO PREVENT VIRAL ASSOCIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 11/561363 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13169 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196389.pdf [firstpage_image] =>[orig_patent_app_number] => 11561363 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/561363
VIRAL GENE PRODUCTS AND METHODS FOR VACCINATION TO PREVENT VIRAL ASSOCIATED DISEASES Nov 16, 2006 Abandoned
Array ( [id] => 4886358 [patent_doc_number] => 20080260690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Interferon in Influenza' [patent_app_type] => utility [patent_app_number] => 12/091985 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6766 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260690.pdf [firstpage_image] =>[orig_patent_app_number] => 12091985 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/091985
Interferon in Influenza Nov 15, 2006 Abandoned
Array ( [id] => 5446127 [patent_doc_number] => 20090047353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS' [patent_app_type] => utility [patent_app_number] => 12/092146 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14084 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047353.pdf [firstpage_image] =>[orig_patent_app_number] => 12092146 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/092146
CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS Nov 5, 2006 Abandoned
Array ( [id] => 5095522 [patent_doc_number] => 20070117131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process' [patent_app_type] => utility [patent_app_number] => 11/592336 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4760 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117131.pdf [firstpage_image] =>[orig_patent_app_number] => 11592336 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/592336
Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process Nov 2, 2006 Abandoned
Array ( [id] => 5188014 [patent_doc_number] => 20070166322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'ADJUVANT VIRAL PARTICLE' [patent_app_type] => utility [patent_app_number] => 11/556678 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 27694 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166322.pdf [firstpage_image] =>[orig_patent_app_number] => 11556678 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/556678
Vaccines and immunopotentiating compositions and methods for making and using them Nov 2, 2006 Issued
Array ( [id] => 6125572 [patent_doc_number] => 20110086065 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2011-04-14 [patent_title] => 'Lentival Vector-Based Vaccine' [patent_app_type] => utility [patent_app_number] => 12/083532 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13924 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0086/20110086065.pdf [firstpage_image] =>[orig_patent_app_number] => 12083532 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/083532
Lentiviral vector-based vaccine Oct 16, 2006 Issued
Array ( [id] => 6125572 [patent_doc_number] => 20110086065 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2011-04-14 [patent_title] => 'Lentival Vector-Based Vaccine' [patent_app_type] => utility [patent_app_number] => 12/083532 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13924 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0086/20110086065.pdf [firstpage_image] =>[orig_patent_app_number] => 12083532 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/083532
Lentiviral vector-based vaccine Oct 16, 2006 Issued
Array ( [id] => 5547013 [patent_doc_number] => 20090156890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'PEROXISOME PROLIFERATOR-ACTIVATOR RECEPTOR DELTA (PPARDELTA) AND THE DEVELOPMENT OF PREIMPLANTATION EMBRYOS' [patent_app_type] => utility [patent_app_number] => 12/090060 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13302 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156890.pdf [firstpage_image] =>[orig_patent_app_number] => 12090060 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/090060
Peroxisome proliferator-activator receptor δ (PPARδ) and the development of preimplantation embryos Oct 11, 2006 Issued
Array ( [id] => 5315909 [patent_doc_number] => 20090280507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'METHOD FOR MEASUREMENT OF SARS VIRUS NUCLEOCAPSID PROTEIN, REAGENT KIT FOR THE MEASUREMENT, TEST DEVICE, MONOCLONAL ANTIBODY DIRECTED AGAINST SARS VIRUS NUCLEOCAPSID PROTEIN, AND HYBRIDOMA CAPABLE OF PRODUCING THE MONOCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/090055 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11810 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280507.pdf [firstpage_image] =>[orig_patent_app_number] => 12090055 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/090055
METHOD FOR MEASUREMENT OF SARS VIRUS NUCLEOCAPSID PROTEIN, REAGENT KIT FOR THE MEASUREMENT, TEST DEVICE, MONOCLONAL ANTIBODY DIRECTED AGAINST SARS VIRUS NUCLEOCAPSID PROTEIN, AND HYBRIDOMA CAPABLE OF PRODUCING THE MONOCLONAL ANTIBODY Oct 10, 2006 Abandoned
Array ( [id] => 5302941 [patent_doc_number] => 20090297593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 12/083209 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15272 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297593.pdf [firstpage_image] =>[orig_patent_app_number] => 12083209 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/083209
Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment Oct 4, 2006 Abandoned
Array ( [id] => 5204502 [patent_doc_number] => 20070025982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'DNA vaccines encoding antigen linked to a domain that binds CD40' [patent_app_type] => utility [patent_app_number] => 11/542423 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6987 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20070025982.pdf [firstpage_image] =>[orig_patent_app_number] => 11542423 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/542423
DNA vaccines encoding antigen linked to a domain that binds CD40 Oct 2, 2006 Abandoned
Array ( [id] => 5252778 [patent_doc_number] => 20070134234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Immunomodulatory compositions and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/541449 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 61823 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134234.pdf [firstpage_image] =>[orig_patent_app_number] => 11541449 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/541449
Immunomodulatory compositions and uses therefor Sep 28, 2006 Abandoned
Array ( [id] => 5172606 [patent_doc_number] => 20070073039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Peptides that inhibit viral infections' [patent_app_type] => utility [patent_app_number] => 11/541488 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 47478 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20070073039.pdf [firstpage_image] =>[orig_patent_app_number] => 11541488 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/541488
Peptides that inhibit viral infections Sep 28, 2006 Abandoned
Array ( [id] => 8188892 [patent_doc_number] => 08183044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Recombinant human hepatitis C virus-like particle and method for producing the same' [patent_app_type] => utility [patent_app_number] => 11/992646 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15117 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183044.pdf [firstpage_image] =>[orig_patent_app_number] => 11992646 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/992646
Recombinant human hepatitis C virus-like particle and method for producing the same Sep 28, 2006 Issued
Array ( [id] => 10082498 [patent_doc_number] => 09119828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Antibodies with simultaneous subsite specificities to protein and lipid epitopes' [patent_app_type] => utility [patent_app_number] => 11/525574 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 12575 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11525574 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/525574
Antibodies with simultaneous subsite specificities to protein and lipid epitopes Sep 21, 2006 Issued
Array ( [id] => 5004979 [patent_doc_number] => 20070202549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Assessing risk of cerebrovascular thrombosis by measuring C4d on platelets' [patent_app_type] => utility [patent_app_number] => 11/521643 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4561 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202549.pdf [firstpage_image] =>[orig_patent_app_number] => 11521643 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/521643
Assessing risk of cerebrovascular thrombosis by measuring C4d on platelets Sep 13, 2006 Abandoned
Array ( [id] => 5148677 [patent_doc_number] => 20070048736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'HEPATITIS' [patent_app_type] => utility [patent_app_number] => 11/466831 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7401 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048736.pdf [firstpage_image] =>[orig_patent_app_number] => 11466831 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/466831
HEPATITIS Aug 23, 2006 Abandoned
Array ( [id] => 4791681 [patent_doc_number] => 20080292654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Human Bocavirus and Methods of Diagnosis and Treatment' [patent_app_type] => utility [patent_app_number] => 12/094135 [patent_app_country] => US [patent_app_date] => 2006-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9570 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292654.pdf [firstpage_image] =>[orig_patent_app_number] => 12094135 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/094135
Human Bocavirus and methods of diagnosis and treatment Aug 15, 2006 Issued
Array ( [id] => 5409597 [patent_doc_number] => 20090123495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Immune Response Inducing Preparations' [patent_app_type] => utility [patent_app_number] => 12/063388 [patent_app_country] => US [patent_app_date] => 2006-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11446 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123495.pdf [firstpage_image] =>[orig_patent_app_number] => 12063388 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/063388
Immune Response Inducing Preparations Aug 7, 2006 Abandoned
Array ( [id] => 5182587 [patent_doc_number] => 20070053933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 11/458945 [patent_app_country] => US [patent_app_date] => 2006-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55354 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20070053933.pdf [firstpage_image] =>[orig_patent_app_number] => 11458945 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/458945
IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME Jul 19, 2006 Abandoned
Menu